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A B S T R A C T
Polycyclic aromatic compounds (PACs), including polycyclic aromatic hydrocarbons (PAHs) and oxygenated
PAHs (oxy-PAHs), are common environmental pollutants known to cause health effects in humans and wild-life.
In particular, vertebrate cardiovascular development and function are sensitive to PACs. However, the inter-
active effects of PAHs and oxy-PAHs on cardiovascular endpoints have not been well studied. In this study, we
used zebrafish embryos (ZFEs) as a model to examine developmental and cardiovascular toxicities induced by
the three environmental oxy-PAHs benzo[a]fluorenone (BFLO), 4H-cyclopenta[def]phenanthren-4-one (4H-
CPO) and, 6H-benzo[cd]pyren-6-one (6H-BPO), and the PAH benzo[a]pyrene (BaP) either as single exposures or
binary oxy-PAH + PAH mixtures. 6H-BPO induced developmental and cardiovascular toxicity, including re-
duced heartbeat rate and blood flow, at lower doses compared to the other compounds. Exposure to binary
mixtures generally caused enhanced toxicity and induction of aryl hydrocarbon receptor (AhR)-regulated gene
expression (ahr2 and cyp1a) compared to single compound exposure. This was associated with differential ex-
pression of genes involved in cardiovascular development and function including atp2a2, myh6, tbx5 and zerg.
AhR-knock-down significantly reduced the cardiovascular toxicity of 6H-BPO and its binary mixture with BaP
indicating a significant AhR-dependence of the effects. Measurements of internal concentrations showed that the
toxicokinetics of BaP and 6H-BPO were altered in the binary mixture compared to the single compound ex-
posure, and most likely due to CYP1 inhibition by 6H-BPO. Altogether, these data support that similar to in-
teractions between PAHs, mixtures of PAHs and oxy-PAHs may cause increased developmental and cardiovas-
cular toxicity in ZFEs through an AhR-dependent mechanism.
1. Introduction
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environ-
mental toxic contaminants and have been established to cause geno-
toxicity, developmental and cardiac toxicity in exposed organisms
(Billiard et al., 2008; IARC, 2010; Geier et al., 2018). The regulation of
PAHs has been restricted to benzo[a]pyrene (BaP) and 27 other priority
PAHs as designated by the U.S. Environmental Protection Agency (U.S.
EPA) and European Union (EU) (European Union, 2005; U.S. EPA,
2010). However, chemicals are present in the environment in intricate
mixtures and PAHs are no exception. Other classes of polycyclic aro-
matic compounds (PACs) such as oxygenated PAHs (oxy-PAHs) are
normally found together with PAHs in the environment and can thus
contribute to the toxicity significantly (Lundstedt et al., 2007).
Oxy-PAHs are widely spread in the environment and can be found in
similar or higher levels than their parent compounds (Lundstedt et al.,
2007). In addition, they are more mobile in the environment, which can
result in higher bioavailability and elevated risk for human health and
the environment (Lundstedt et al., 2007; Layshock et al., 2010; Idowu
et al., 2019). Bandowe et al. showed that measured concentrations of
Ʃ15 oxy-PAHs in various fish species were higher than Ʃ16 US EPA
priority PAHs (Bandowe et al., 2014). Although PAHs, oxy-PAHs and
other PACs are normally present in mixtures, few studies have focused
on the effects of these mixtures. Using environmental PAC samples
obtained from contaminated soils, Wincent et al showed that the polar
fraction including oxy-PAHs may cause enhanced or similar
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developmental toxicity in fish compared to the non-polar PAH fraction
(Wincent et al., 2015a). Exposures to single oxy-PAHs show develop-
mental and genotoxic effects in zebrafish (Danio rerio) and Japanese
medaka (Oryzias latipes) (Knecht et al., 2013; Dasgupta et al., 2014;
Geier et al., 2018; McCarrick et al., 2019). It is further unknown
whether toxicokinetic processes are altered in a mixture exposure
compared to single exposure. Therefore, more studies are needed to
understand the interactions between PAHs and other PACs on tox-
icokinetic and toxicodynamic processes.
Cardiac development is particularly sensitive to environmental
pollution (Sarmah and Marrs, 2016) and cardiotoxicity due to PAH
exposure is well established. Different experimental and epidemiolo-
gical studies indicate the involvement of PAHs in the pathogenesis of
cardiovascular diseases in humans (Korashy and El-Kadi, 2006; Holme
et al., 2019). Persistent cardiac damage has also been observed in fish
exposed to oil spills or sediments at PAH contaminated sites (Incardona
et al., 2014, 2015; Brown et al., 2017). Due to the conserved physiology
compared to humans, zebrafish (D. rerio) has increasingly been used as
a model for studying cardiotoxicity, cardiac development and cardiac
disease (MacRae and Peterson, 2015; Sarmah and Marrs, 2016). Cardiac
development in zebrafish can be observed throughout embryogenesis
and is divided in two phases. In the first phase, which takes place from
0 to 28 h post fertilization (hpf), the primitive tube heart develops. In
the second phase, the separation of late-differentiating cardiomyocytes
form two chambers and looping of the heart occurs, resulting in a two
chambered heart at around 48 hpf (de Pater et al., 2009; Miura and
Deborah, 2011). Cardiac defects, caused by xenobiotics for example,
may manifest by pericardial edema or deficient looping of the heart
resulting in tubular or so-called string heart that may cause disruption
of heart rhythm (e.g. arrhythmia and bradycardia) and reduced blood
flow (Miura and Deborah, 2011; Incardona et al., 2014; Le Bihanic
et al., 2015). Importantly, cardiotoxicity has been shown to be an early
event in PAC toxicity in fish, with morphological deformities as sec-
ondary effects (Incardona et al., 2004).
To date, the mechanism of PAC-induced cardiotoxicity in fish has
not been fully understood. Available data show that PAHs can induce
cardiotoxicity through activation of the aryl hydrocarbon receptor
(AhR) and subsequent CYP1A induction, leading to morphological and
functional defects on the cardiovascular system in zebrafish (Incardona
et al., 2011; Van Tiem and Di Giulio, 2011). In contrast, PAH mixtures
derived from crude oil or smaller tricyclic PAHs, such as phenanthrene,
cause cardiotoxicity in an AhR-independent manner, leading to cardiac
function impairment and morphological deformities (Incardona et al.,
2004, 2005; Brette et al., 2017). Deregulation of AhR activation and
signaling has also been suggested to be involved in the observed non-
additive genotoxic and tumorigenic effects of simple and complex PAH
mixtures (Jarvis et al., 2014). Recent studies have demonstrated that
PAHs can cause cardiotoxicity by impairing the excitation–contraction
(EC) coupling in fish heart (Brette et al., 2014, 2017a). Although pre-
vious studies have indicated both AhR-dependent and -independent
mechanisms in zebrafish, relatively little is known about how oxy-PAHs
and other polar PACs cause cardiotoxicity (Knecht et al., 2013; Goodale
et al., 2015; Geier et al., 2018). We have previously shown that the oxy-
PAHs benzo[a]fluorenone (BFLO) and 6H-benzo[cd]pyren-6-one (6H-
BPO) efficiently inhibited AhR activation by 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) in human HaCaT cells (Wincent et al.,
2016), suggesting that interaction effects might arise from PAC mix-
tures.
This work aimed to determine the effects of binary PAH/oxy-PAH
mixtures on the developing zebrafish embryo with focus on the cardi-
otoxicity of these compounds. To this end, developmental and cardio-
vascular toxicities were assessed in zebrafish embryos exposed to single
oxy-PAHs or in combination with BaP. Moreover, expression levels of
genes and proteins related with AhR-signaling and cardiovascular de-
velopment and function were measured. The role of AhR-signaling was
investigated by use of morpholinos targeting the zebrafish AhR gene
ahr2. In addition, we measured internal concentrations of these com-
pounds alone and in a mixture to better understand the toxicokinetic
processes including possible toxicokinetic and toxicodynamic altera-
tions.
2. Material and methods
2.1. Chemicals
The three ketone oxy-PAHs benzo[a]fluorenone (BFLO) (CAS-Nr
479-79-8), 4H-cyclopenta[def]phenanthren-4-one (4H-CPO) (CAS-Nr
5737-13-3) and 6H-benzo[cd]pyren-6-one (6H-BPO) (CAS-Nr 3074–00-
8), all with purity ≥ 99%, were obtained from the Institute for
Reference Materials and Measurements (EC-JRC-IRMM, Belgium).
Chemical structures are shown in Fig. 1. Benzo[a]pyrene (BaP) (CAS-Nr
50-32-8; purity ≥ 96%), dimethyl sulfoxide (DMSO, purity 96%) and
pyrene (CAS-Nr 129-00-0; purity 99%) were obtained from Sigma Al-
drich, Sweden. Acetonitrile (ACN, gradient grade for HPLC) was ob-
tained from VWR, Sweden.
2.2. Zebrafish and exposure
Zebrafish embryos (ZFEs) of AB wild-type strain and transgenic
cardiac myosin light chain 2 [Tg (cmlc2:GFP)] were used in the ex-
periments. Fertilized eggs were obtained from the Zebrafish Core
Facility at Comparative Medicine, Karolinska Institutet, and held at
28 °C in embryo medium (EM, 5.0 mM NaCl, 0.17 mM KCl, 0.33 mM
CaCl2, 0.33 mM MgSO4) in a thermo-regulated chamber (IPP110 plus,
Memmert, Germany). At 24 h post fertilization (hpf), groups of 30
embryos (in 30 mL) per replicate were exposed to 0.1–1 µM single
compound, a mixture of oxy-PAH plus BaP (1 μM), or solvent control
(0.01% DMSO (v/v)) up to 120 hpf. Due to solubility issues, 6H-BPO
was used up to 0.5 µM. Compounds dissolved in DMSO were added
directly to EM and immediately mixed by gently swirling the dish. All
exposures were performed in glass Petri dishes and all given con-
centrations are nominal concentrations unless otherwise stated. All
experiments were performed in at least triplicates.
2.3. AhR knock-down in zebrafish by morpholinos
Knock-down of AhR was performed as previously described
(Wincent et al., 2015a). A morpholino antisense oligonucleotide tar-
geting ahr2 (ahr2-MO; 5′-TGTACCGATACCCGCCGACATGGTT- 3′) and
blocking its translation (Prasch et al., 2003) and a negative control
Fig. 1. Chemical structures of PACs used in the study; benzo[a]fluorenone (A,
BFLO), 6H-benzo[cd]pyren-6-one (B, 6H-BPO), 4H-cyclopenta[def]phenan-
threne-4-one (C, 4H-CPO), and benzo[a]pyrene (D, BaP).
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morpholino (CT-MO; 5′-CCTCTTACCTCAGTTACAATTTATA- 3′) (Gene
Tools, Philomath, OR) were used. Both morpholinos (0.15 mM) were
injected into Tg (cmlc2:GFP) embryos at 2- to 4-cell stage using an
Eppendorf FemtoJet injector (Eppendorf, Germany). At 6–8 hpf, ZFEs
were screened by fluorescence microscopy to verify incorporation of
morpholinos. Damaged embryos or those not displaying homogeneous
fluorescence were removed.
2.4. Determination of toxicokinetics
Three different exposure scenarios were set-up for determining the
toxicokinetics of either 6H-BPO and BaP alone or as a mixture in ZFEs
according to Vogs et al. (2019). First, a “ZFE-free medium” consisting of
EM without ZFE was prepared to rule out unspecific loss due to che-
mical adsorption to glass surface, hydrolysis or evaporation. Second, a
“biological control” was set up by incubating ZFE in EM without ad-
dition of chemical. Third, ZFEs were exposed as described above with
one ZFE per mL EM. Exposures took place from 24 hpf up to 120 hpf
and samples were collected at 27, 30, 33, 48, 55, 72, 96 and 120 hpf.
Triplicates of 300 µL aliquots from EM samples of both ZFE-free control
and ZFE-medium were transferred to amber HPLC glass vials (2 mL,
Agilent, Sweden). Five replicates per sample time point consisting of
five ZFEs were collected in 1.5 mL Eppendorf microtubes, excessive EM
was discarded and ZFE were washed with double-distilled water
(ddH20) two times. All samples were stored at –80 °C until further
sample preparation and chemical analysis.
Before analysis by high performance liquid chromatography
(HPLC), 700 µL of an internal standard (10 µM pyrene dissolved in
100% ACN) was added to EM samples. To the ZFE samples, 300 µL of
the internal standard dissolved in ACN:ddH20 (70%:30%, v:v) was
added followed by homogenization using 1 mm diameter zirconium
oxide beads (Next Advance, NY). The supernatant was transferred to
clean 1.5 mL tubes. Remaining beads were washed once with 100 µL of
ACN:ddH20 (70%:30%, v:v) and the supernatant subsequently added to
the ZFE homogenate in order to account for chemical adsorption at the
beads’ surface. The homogenate was cleared by centrifugation at 14
000 rpm for 5 min and the final supernatant transferred to amber HPLC
glass vials.
EM and ZFE samples were analyzed using an YL9100 HPLC system
equipped with an Agilent 1100 UV detector (both from Dalco
ChromTech, Sweden). PACs were separated on a 150 mm long, 5 μm
particle size reverse phase ACE C18-AR column (Scantec Lab, Sweden)
using a 25 min gradient elution. Gradient was from 70% B to 100% B
for 22 min and then back to 70% B at 25 min (solvent A, 1.5 mM formic
acid in ddH2O; solvent B, 1.5 mM formic acid in ACN) at a flow rate of
1 mL/min. 6H-BPO and BaP were detected by UV at 250 nm and
254 nm, respectively, and quantified according to respective calibration
curves. Outliers were identified by nonlinear regressions using the
ROUT method in GraphPad Prism 7 and removed.
The concentration declines in the ZFE-free medium and ZFE
medium (Cw in µmol L-1) were simulated using an exponential function




k C( )w w w
A one-compartment model was used to simulate the time courses of
the internal concentrations (Cint in µmol L-1 ZFE volume (= µM)):
= × − + ×
dC t
dt
k C k k C( ) ( )int in w out m int
where kin is the uptake rate constant (h−1), kout the elimination rate
constant (h−1) and km the biotransformation rate constant (h−1). In
addition, the biotransformation capacity km was assumed to linearly
increase over time to obtain better fitting results. All simulations were
conducted in Berkeley Madonna (version 8.3.18).
2.5. Assessment of morphological effects and mortality
At 96 hpf, ZFEs were assessed under a Nikon SMZ25 microscope
(Nikon, Japan) and selected endpoints (mortality, pericardial and yolk
sac edema, swim-bladder inflation, string heart) were scored (%) as
being either present or absent. Zebrafish mortality was controlled every
day during exposure time and dead embryos were discarded daily.
Cumulative effects were calculated at 96 hpf as the sum of lethal or
sublethal endpoints. Results are expressed as mean ± SE of 3–10 re-
plicates with a pool of 10 embryos per replicate.
2.6. Cardiac function analysis
For cardiac function analysis, heartbeat rate and blood flow at the
caudal vein were recorded on 26–86 individual ZFEs per condition at
96 hpf using a Nikon SMZ25 microscope and NIS-Elements Imaging
Software (Nikon, Japan). Prior to analysis, ZFEs (5 per well in a 24-well
plate) were anesthetized (0.168 mg/mL tricaine solution, Sigma
Aldrich, Sweden) for 1–3 min. Next, the ZFEs were placed in a drop of
3% methylcellulose in a petri-dish and incubated for 3 min in dark at
28 °C. The petri-dish was placed under the microscope equipped with a
glass heating plate set at 28 °C (Okolab, Italy), and left to acclimatize
for 2 min. The recording of the video was made with a frame rate at
around 17 fps and 2560 × 1920 resolution and for 10 sec. Effects on
cardiac function were assessed by measuring heartbeat rate and blood
flow using the DanioScope software (Noldus, Netherlands) according to
instructions. The heart area was determined by manually tracing the
heart with DanioScope software tools. To measure blood flow, videos
containing up to 5 larvae were recorded using a microscope magnifi-
cation at 20x. In DanioScope, the area of the blood vessel was selected
using a circle with a diameter of 2 mm ± 0.5 mm. The area was copied
to all larvae present in the same video to ensure standardization. In
both cases, DanioScope uses changes in pixels on a frame-by-frame
basis to measure the endpoints. The heart rate is reported as number of
beats per minute (BPM) and the blood flow in a percentage of activity
within that area (%) by DanioScope.
2.7. In vivo EROD activity measurement
Ethoxyresorufin-O-deethylase (EROD) activity in vivo was measured
according to previous published protocol (Perrichon et al., 2014) with
some minor changes. At 96 hpf, a total number of 10 larvae per treat-
ment were selected and divided into two wells in a 24-well plate (five
individuals per well). The exposure solution was replaced by 1 μM 7-
ethoxyresorufin (Sigma Aldrich, Sweden) in EM. After 3 h incubation in
dark, the fluorescence of the incubation media was measured in du-
plicate. Production of resorufin was determined using a Victor 3 Wallac
plate reader (Perkin Elmer, MA) with ex/em: 560/590 nm and results
were expressed as pmol of resorufin produced/larvae/min. A standard
curve of EROD activity was performed using resorufin dilutions.
2.8. RNA purification and quantitative Real-Time PCR (qRT-PCR)
Samples of group replicates composed of 10 pooled larvae were
collected at 96 hpf for gene expression analysis and stored in RNAlater
(Sigma Aldrich, Sweden). RNA from zebrafish was purified using
ReliaPrep RNA Tissue Miniprep System kit (Promega, Sweden) followed
by cDNA synthesis using High-Capacity cDNA Reverse Transcription kit
(Applied Biosystems, Sweden) according to manufacturer’s protocols.
RNA quantification and quality were verified by measurement of the
ratio of optical density at λ260/280 nm using NanoDrop 1000 (Thermo
Scientific, Sweden). Reactions for qRT-PCR were performed on an
Applied Biosystem 7500 Real-Time PCR system (Applied Biosystem,
Foster City, CA) using Maxima SYBR Green qPCR Master Mix (Thermo
Fisher, Sweden). Conditions were as follows: 95 °C for 2 min, and then
40 cycles at 95 °C for 15 s and 60 °C for 1 min. At the end of each run, a
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melting curve analysis was done to determine the formation of the
specific products. The relative expression ratio was calculated with
comparative threshold cycle method (2−ΔΔCt) using l13 as reference
gene. Primer sequences are given in Table S1.
2.9. Western blot
At 96 hpf, 30 larvae were transferred to pre-chilled tubes with EM
and the yolk was mechanically disrupted. Each sample was homo-
genized in 1 × IPB7 lysis buffer supplemented with Halt™ Protease and
Phosphatase Single-use Inhibitor Cocktail (Thermo Scientific, Sweden)
and PMSF (Sigma-Aldrich, Sweden) and snap frozen in cryotubes using
liquid N2. Protein concentrations were measured by Bradford method
(Bradford, 1976), and samples were further processed and analyzed by
immunoblotting as previously described (Edmunds et al., 2015). The
proteins were detected using antibodies against Tbx5 (1:1000, cat no.
ARP33403) and Zerg (1:500, cat no. P35480) from Aviva Systems
Biology, San Diego, CA. Actin was used as loading control (1:1000, cat
no. sc-1615, Santa Cruz Biotechnology, Santa Cruz, CA). Proteins were
visualized with enhanced chemiluminescence (Amersham Biosciences,
Sweden). Densitometry analysis was performed using ImageJ software
(National Institute of Health, USA). The experiments were performed at
least in triplicates.
2.10. Statistics
Data are presented as mean ± standard error. Analysis of variance
among exposures compared to control was evaluated by Kruskal-Wallis
or one-way ANOVA, followed by a multiple comparison test (Dunn’s
test and Bonferroni’s test, respectively). For binary mixtures with a
significant effect on morphological and functional endpoints, this was
followed up by a statistical analysis in comparison with oxy-PAH alone
using a two-sided Student’s t-test. Data from mRNA expression were log
transformed to fit ANOVA assumptions. Statistical significance of de-
viation from additive effects on gene and protein expression were de-
termined using a two-sided Student’s t-test with a False Discovery Rate
approach (Q = 10%) to adjust for multiple testing. For this analysis,
additive effects were estimated by summing the values from the single
exposures (BaP plus BFLO, 4H-CPO or 6H-BPO, respectively) and sub-
sequently compared to the observed effects from the binary oxy-
PAH + BaP exposure. Tests were performed using Statistica 7 (Statsoft,
Inc) or GraphPad Prism 7 (GraphPad Software, Inc). Principal compo-
nent analysis (PCA, two axes) of the exposures and the different mea-
sured endpoints was performed using R software coupled with the
FactoMineR package (Le et al., 2008). Correlation analyses between
morphological and functional endpoints were based on Pearson’s cor-
relation coefficients with two-tailed p-values. The criterion for sig-
nificance was set at P < 0.05.
3. Results
3.1. Effects on morphological and cardiovascular endpoints
Developmental toxicity including mortality following exposure to
different concentrations of BFLO, 4H-CPO, 6H-BPO, BaP or PAH+ oxy-
PAH combinations at 96 hpf are presented in Table 1. Mortality was not
increased in response to any exposure. Exposure to BaP alone at 1 µM
did not induce any significant effects on either morphological or
functional endpoints, although about one third of the ZFEs did not have
inflated swim-bladder at 96 hpf (P= 0.07). Results further showed that
6H-BPO was the most potent developmental toxicant with decreased
swim-bladder inflation starting from the lowest dose of 0.1 µM
(P < 0.01) and an increased incidence of pericardial edema from
0.3 µM (P < 0.05). Moreover, 6H-BPO was the only oxy-PAH that
induced string heart formation. All oxy-PAHs caused a reduced heart-
beat rate, up to a 20% reduction in the case of 6H-BPO (P < 0.001),
although a clear dose-response could not be observed. In agreement
with the formation of string heart and reduced heartbeat rate, 6H-BPO
reduced the blood flow in the caudal vein more than 8-fold compared to
control (0.6 vs 5.0%, P < 0.0001). Notably, a large proportion of these
embryos completely lacked circulating red blood cells. The other two
oxy-PAHs did not reduce the blood flow when applied as single com-
pounds. A combined exposure of BFLO or 4H-CPO with BaP did not
increase the incidence of morphological effects compared to single
compound exposures. However, both heartbeat rate and blood flow
were more strongly reduced by these binary mixtures compared to
control (P < 0.05 – 0.0001) and in the case of BFLO + BaP also
compared to the oxy-PAH alone (P < 0.05). Exposure to the combi-
nation of 6H-BPO and BaP increased the incidence of both yolk sac and
pericardial edema, both in comparison with control and oxy-PAH alone
(P < 0.05 – 0.001). Notably, the blood flow was increased in response
to the binary exposure compared to oxy-PAH alone (3.1 vs 0.6%,
P < 0.05), but still decreased compared to control (P < 0.01). In
summary, among the three tested oxy-PAHs 6H-BPO was the most
potent developmental and cardiovascular toxicant and the effects were
further increased when co-exposed with BaP.
3.2. Effects on AhR signaling and CYP1 activity
In previous in vitro and in vivo studies, oxy-PAHs have been shown to
both activate and inhibit AhR signaling and cytochrome P450 family
member 1 (CYP1) activity (Knecht et al., 2013; Wincent et al., 2016).
To comprehend the impact of BFLO, 4H-CPO, and 6H-BPO alone and in
combination with BaP in ZFEs, gene expression levels of cytochrome
P450 family member 1a (cyp1a) and AhR (ahr2), as well as CYP1 en-
zyme activity (EROD activity) were investigated. In embryos exposed to
oxy-PAHs alone, mRNA expression of cyp1a and ahr2 was decreased for
most of the concentrations compared to control (Fig. 2A and B). This
down regulation was enhanced for ahr2 (0.02 – 0.07-fold, P < 0.05 –
0.0001). Exposure to 1 µM BaP resulted in induced expression of cyp1a
(4-fold, P < 0.05) and reduced expression of ahr2 (0.06-fold,
P < 0.001) compared to control. In general, an upregulation in gene
expression was observed in embryos exposed to the binary mixtures.
The combined exposure of 0.3 µM 4H-CPO or 6H-BPO with BaP resulted
in a more than additive increased cyp1a expression (6.5- and 14.9-fold,
P < 0.05 – 0.01) compared to single compound exposure. In contrast,
the mixture of BFLO and BaP caused a more than additive decreased
cyp1a expression at all doses (P < 0.001). For ahr2, the effect of the
binary mixtures with BFLO and 4H-CPO was the reverse compared to
single compound exposures, resulting in an up to 4-fold increase of
expression. This was especially evident for the mixtures with 0.1 and
1 µM BFLO and 0.3 µM 4H-CPO (P < 0.05 – 0.01). The mixture of 6H-
BPO + BaP did not result in any interaction effects and resulted in
similarly reduced ahr2 expression levels as for single compound ex-
posures. Measurements of CYP1 enzyme activity did not reveal any
clear effects (Fig. 2C). Single compound exposures did not result in
changes in EROD activity. A trend was observed that the binary mix-
tures increased enzyme activity, which was especially clear for
BFLO + BaP (P < 0.05), compared to control. In total, these results
indicate a complex pattern of interaction effects of oxy-PAHs and BaP
on AhR signaling, which might be related to the observed morpholo-
gical and functional effects.
3.3. Effects on regulators of cardiac development and function
To understand the interaction effects of oxy-PAHs and PAHs on the
cardiac development and function in ZFEs, we evaluated expression of
mRNA transcripts of a set of genes encoding proteins that play a key
role in these functions (Fig. 3). The four selected genes can be divided
in two groups according to their related function. (i) Genes associated
with excitation-contraction (EC) coupling; the calcium transport AT-
Pase encoded by atp2a2 and the potassium voltage-gated channel
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encoded by zerg (also known as kcnh2). (ii) Genes associated with
cardiac development and function; myosin heavy chain encoded by
myh6, the T-box transcription factor encoded by tbx5, and troponin T
encoded by tnnt2.
The results showed that mixtures of oxy-PAHs and PAHs could
disrupt mRNA expression of genes coding for proteins involved in EC
coupling (Fig. 3A and B). Expression of atp2a2 was upregulated by
exposure to BaP (3.9-fold, P < 0.05) and showed a tendency to be
upregulated by BFLO and 4H-CPO (>2-fold but P > 0.05). Atp2a2
was the only gene whose expression was affected by BaP. For all oxy-
PAHs, exposure to the binary mixture with BaP caused a more than
additive repression of induction of atp2a2 compared to the single
compounds at one or more doses (P < 0.05 – 0.01). For zerg, exposure
to BaP, BFLO or 4H-CPO did not affect gene expression levels while 6H-
BPO increased expression levels at the two higher doses about 5-fold
but with P > 0.05. A trend could be observed that the binary mixtures
further induced zerg expression levels, which was especially evident for
0.1 µM 4H-CPO+ BAP compared to single compounds (P < 0.05). For
genes involved in cardiac development (Fig. 3C - E), the results showed
that expression levels of myh6 were induced about 6-fold by 0.5 µM 6H-
BPO (P < 0.05) compared to control, which became repressed when
co-exposed to BaP (0.45-fold, P < 0.05). Similar to ahr2, the binary
mixture of 4H-CPO + BaP caused the reverse effect of the individual
compounds, with up to 5.4-fold induction of myh6 by the mixture with
0.3 µM 4H-CPO (P < 0.01 compared to control and P < 0.0001
compared to the single compounds). For tbx5, strongest effects were
observed in response to 6H-BPO, both alone and in combination with
BaP, with an up to 12-fold induction of expression (P < 0.05) com-
pared to control. Similar to myh6, the binary mixture of 4H-CPO and
BaP caused a more than additive induction of tbx5 expression compared
to single compounds (P < 0.01). Expression levels of tnnt2 were in
general unaffected, although a tendency of repressed expression levels
in response to BFLO and 4H-CPO were observed (> 0.5-fold but
P > 0.05). Altogether, the results indicate that binary mixtures
showed a more than additive effect on the selected genes related in
cardiac development and function compared to single PACs exposure.
The protein levels of Tbx5 and Zerg in the ZFE were evaluated
(Fig. 4A and B). Both protein levels were increased in embryos exposed
to oxy-PAHs alone and in combination with BaP, especially Zerg in
response to 4H-CPO and 6H-BPO alone (P < 0.05 – 0.01), and 6H-
BPO + BaP. These data support the gene expression results, especially
for 6H-BPO and Zerg.
3.4. Role of AhR activation and impact on toxicokinetics
Based on its high potency, the mixture of 6H-BPO and BaP was
chosen for further studies with the aim to investigate the role of AhR
and if the mixture exposure affected their toxicokinetics. Knock-down
of AhR with morpholinos against ahr2 (MO_AhR) in ZFEs clearly res-
cued the cardiotoxic effects caused by BaP (1 µM), 6H-BPO (0.3 µM)
and their binary mixture (Fig. 5 and Table 2). For example, the high
incidence of pericardial edema (60%) and string heart formation (43%)
in response to the binary mixture was completely abolished. Similarly,
knock-down of AhR rescued the heartbeat rate and blood flow to levels
similar to control ZFE (P < 0.01 – 0.0001).
We further investigated the toxicokinetics of 6H-BPO and BaP alone
and in combination (Fig. 6, Table S2). Initial concentrations of 6H-BPO
and BaP were 0.61 µM and 0.67 µM; 50% higher and 30% lower than
the nominal exposures used for the effect characterizations (0.3 and
1 µM, respectively). Concentrations decreased in ZFE-free medium and
in ZFE medium for both single exposure and mixture exposure (Fig. 6A,
B, C, D). The decline of BaP in the ZFE-free medium and ZFE medium
was similar, while 6H-BPO decreased twice as fast in the ZFE medium
than in the ZFE-free medium. These results indicated that both
Table 1










String heart (%) Heartbeat (BPM) Rel. heartbeat Blood flow (%) Rel.
blood
flow
Solvent control 0 1.0 ± 1.0a 94 ± 2.2 0 0 0 187 ± 5 5.1 ± 0.4
BFLO 0.1 0 83 ± 8.8 0 3.3 ± 3.3 0 167 ± 4 ↓ ndb
0.3 3.3 ± 3.3 77 ± 6.7 0 0 0 172 ± 6 ↓ 4.1 ± 0.4 ≈
1 3.3 ± 3.3 77 ± 3.3 0 3.3 ± 3.3 0 183 ± 4 ≈ nd
BFLO + BaP 0.1 3.3 ± 3.3 77 ± 6.7 0 3.3 ± 3.3 3.3 ± 3.3 153 ± 4****, ‡ ↓↓↓ nd
0.3 0 73 ± 22 0 10 ± 0 6.7 ± 6.7 182 ± 5 ≈ 2.3 ± 0.3****, ‡ ↓↓
1 6.7 ± 3.3 63 ± 8.8 0 6.7 ± 6.7 0 169 ± 5 ↓ nd
4H-CPO 0.1 0 83 ± 8.8 0 0 0 169 ± 4 ↓ nd
0.3 6.7 ± 6.7 93 ± 3.3 0 3.3 ± 3.3 0 168 ± 6 ↓ 4.2 ± 0.4 ≈
1 3.3 ± 3.3 73 ± 6.7 0 3.3 ± 3.3 0 164 ± 7* ↓↓ nd
4H-CPO + BaP 0.1 3.3 ± 3.3 70 ± 10 0 3.3 ± 3.3 0 190 ± 4 ≈ nd
0.3 6.7 ± 6.7 83 ± 3.3 0 3.3 ± 3.3 0 174 ± 6 ↓ 3.5 ± 0.4* ↓
1 3.3 ± 3.3 83 ± 3.3 0 0 0 144 ± 7*** ↓↓↓ nd
6H-BPO 0.1 3.3 ± 3.3 37 ± 6.7** 0 27 ± 15 0 178 ± 3 ↓ nd
0.3 6.7 ± 3.3 23 ± 8.8*** 0 53 ± 22* 13 ± 8.8 154 ± 6*** ↓↓↓ 0.6 ± 0.2**** ↓↓↓
0.5 3.3 ± 3.3 43 ± 17* 3.3 ± 3.3 33 ± 23 13 ± 3.3* 161 ± 8** ↓↓ nd
6H-BPO + BaP 0.1 0 53 ± 13 0 20 ± 5.8 13 ± 13 180 ± 5 ≈ nd
0.3 10 ± 10 40 ± 12** 6.7 ± 3.3** 47 ± 19* 47 ± 6.7*** 162 ± 6* ↓↓ 3.1 ± 0.4**,‡ ↓
0.5 6.7 ± 6.7 33 ± 17** 3.3 ± 3.3 67 ± 18** 57 ± 26** 165 ± 6* ↓↓ nd
BaP 1 1.4 ± 1.4 67 ± 6.0 2.9 ± 1.8 7.1 ± 4.2 1.4 ± 1.4 192 ± 5 ≈ 3.8 ± 0.4 ≈
a Results are presented as mean ± standard error, n = 3 – 10 replicates for morphological endpoints and n = 26 – 86 ZFEs for heartbeat and blood flow.
b nd = not determined.
* P < 0.05.
** P < 0.01.
*** P < 0.001.
**** P < 0.0001 as compared to control by Kruskal-Wallis (morphological endpoints) or one-way ANOVA (functional endpoints).
‡ P > 0.05 as compared to oxy-PAH alone by Student’s t-test.
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compounds bound to the glass petri dish and that 6H-BPO displayed a
higher degree of accumulation in the zebrafish embryo compared to
BaP. This was also supported by measurements of internal concentra-
tions of 6H-BPO, which increased until a steady-state condition seemed
to be reached at 96 hpf (Fig. 6F). Exposure to BaP resulted in a fast
uptake in the ZFE up to 27 hpf and decreased thereafter (Fig. 6E). At 96
hpf, an increase in the internal BaP concentration was found, which we
could not explain and was therefore treated as an outlier for the tox-
icokinetic modeling.
In contrast to single compound exposure, the internal concentration
of 6H-BPO in the mixture exposure peaked at 27 hpf and decreased
thereafter, resulting in a 55-fold lower internal concentration at 96 hpf
compared to the exposure of 6H-BPO alone (Fig. 6F). The internal BaP
concentration in the mixture exposure also displayed a fast uptake up to
27 hpf that stayed relative stable up to 120 hpf (Fig. 6E). These results
suggest a competitive interaction between the two compounds resulting
in decreased biotransformation of BaP and increased biotransformation
of 6H-BPO.
3.5. Principal component analysis of developmental and cardiovascular
toxicity caused by oxy-PAHs and PAHs
To analyze the mixture effects on cardiac developmental toxicity, a
principal component analysis (PCA) was conducted on the toxicity and
gene expression data presented above. The first and second principal
components together explained 56.6% of the variance of the data. The
individuals plot identified four clusters (Fig. 7A). The first cluster in-
cluded the control conditions, BaP, and the three concentrations of 4H-
CPO and BFLO, and the lower concentration of 4H-CPO + BaP, which
all displayed low or no toxicity to the ZFE. The second cluster consisted
of the binary mixtures of 4H-CPO and BFLO with BaP, which, compared
to the first group, had a stronger impact on cardiac toxicity and gene
expression. The third cluster included 6H-BPO and its binary mixture at
0.1 µM, while the last cluster included the binary mixtures at 0.3 and
0.5 µM 6H-BPO. These last two groups were clearly the most potent in
inducing cardiotoxicity and deregulation of gene expression compared
to the other groups, and the binary mixtures at higher concentrations
Fig. 2. Relative gene expression of cyp1a (A) and ahr2 (B), and EROD activity (C) in ZFEs exposed to oxy-PAHs alone (0.1–1.0 µM) or in combination with BaP (1 µM)
between 24 and 96 hpf. Data are presented as means ± SE (n = 2 – 5). Analysis of statistical differences between each exposure compared to the DMSO control was
performed using one-way ANOVA (*P < 0.05, **P < 0.01, and ***P < 0.001). Student’s t-test was used for statistical analysis to evaluate whether more or less
than additive effects in co-exposures was shown compared to sum of single exposures (XP < 0.05, XXP < 0.01, and XXXP < 0.001).
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were additionally potent, as observed by high incidence of string heart
formation, and induced expression of zerg and tbx5. The variables factor
map (Fig. 7B) suggested positive correlations between expression of
cyp1a, tbx5, tnnt2 and pericardial edema (PE) or string heart formation
(SH), and negative correlations between expression of zerg, tbx5 and
blood flow (BF), which also was confirmed by correlation analyses
(r > 0.5 and P < 0.05, Table S3).
Notably, expression of cyp1a was not correlated with EROD activity.
4. Discussion
It is well established that weak or non-carcinogenic PAHs can en-
hance or reduce the genotoxicity and tumorigenicity of carcinogenic
PAHs in vitro and in vivo (Jarvis et al., 2014). Similarly, PAH mixtures
containing AhR agonists and CYP1 inhibitors may cause synergistic and
dioxin-like developmental toxicity in fish (Billiard et al., 2008). More
recently, the role of polar PACs in the toxicity of environmental PAH
pollution has been investigated in more detail (Bandowe and Meusel,
2017; Idowu et al., 2019). Available data show that the polar PAC
fraction, including oxy- and nitro-PAHs, of environmental samples may
display similar or higher biological activities as the non-polar PAH-
containing fraction, including genotoxicity, mutagenicity and devel-
opmental effects (Umbuzeiro et al., 2008; Mattsson et al., 2009;
Wincent et al., 2015a, McCarrick et al., 2019). We have previously
shown that binary oxy-PAH + PAH mixtures induce comparable or
greater genotoxic effects than expected compared to the sum effect of
single exposure of oxy-PAHs and BaP in ZFE (McCarrick et al., 2019).
However, there is a dearth of data on how oxy-PAHs and PAHs present
in mixtures might interact in organisms leading to non-additive effects.
Based on previous studies employing PAHs (Incardona et al., 2004,
2005, 2011; Van Tiem and Di Giulio, 2011; Brette et al., 2017) or polar
PACs (Knecht et al., 2013; Chlebowski et al., 2017; Geier et al., 2018),
the cardiovascular system in zebrafish is sensitive to exposure to these
compounds and was thus used here to study mixture effects between
PAHs and oxy-PAHs. We show that binary mixtures of the oxy-PAHs
BFLO or 6H-BPO with BaP, at 1 µM or lower, caused increased devel-
opmental and cardiovascular toxicity in ZFEs compared with oxy-PAH
or BaP alone. The third oxy-PAH, 4H-CPO was the least potent toxicant,
alone and in combination with BaP. The high potency of BFLO and 6H-
BPO agrees with previous results from comparative developmental
toxicity studies of polar PACs performed in ZFE (Knecht et al., 2013;
Geier et al., 2018).
Previous data show that PAHs and PAH mixtures can induce car-
diotoxicity in fish in an AhR-dependent or -independent manner, and
that this seems to depend on the size and structure of PAHs (Incardona
et al., 2004, 2005, 2011; Van Tiem and Di Giulio, 2011; Brette et al.,
2017). Our data suggest that mixtures of oxy-PAHs and PAHs also can
modulate AhR signaling in ZFE. We show that the expression of cyp1a
was increased in response to 4H-CPO + BaP and 6H-BPO + BaP and
decreased by BFLO + BaP compared with control and BaP alone. BaP,
on the other hand, is well-known to be an AhR activator and CYP1
inducer, as was also observed here. Based on our results from cyp1a
gene expression and EROD activity measurements, 4H-CPO and 6H-
BPO seem to be CYP1 inhibitors in ZFE. Although the EROD data is not
fully conclusive, and probably due to differences in sensitivity of these
methods, the potentiation of cyp1a expression by their respective mix-
tures may be interpreted as a result of decreased metabolism of BaP due
to inhibition of CYP1. The lack of cyp1a induction by 4H-CPO agrees
with a previous study in ZFEs (Geier et al., 2018). The function of 4H-
CPO and 6H-BPO as CYP inhibitors is further supported by our previous
study using recombinant human CYP1A1 enzyme and HaCaT cells
showing that 4H-CPO and 6H-BPO were strong CYP inhibitors (Wincent
et al., 2016). The effects on gene expression of ahr2 displayed a com-
plex pattern. The four tested PACs all significantly reduced ahr2 ex-
pression compared to control when tested as single compounds while
two of the mixtures (containing BFLO and 4H-CPO) induced expression
levels. The regulation of ahr2 is not well established although crosstalk
with HIF and WNT signaling pathways has been proposed to be im-
portant for regulating many of the toxic effects mediated by activation
of the AhR (Schneider et al., 2014; Vorrink and Domann, 2014). Indeed,
regulation of the crosstalk between the AhR and WNT signaling path-
ways plays an important role in developmental toxicity in ZFEs
(Wincent et al., 2015; Yue et al., 2017). The possible role of WNT sig-
naling in the effects observed needs further investigation.
Previous studies showed that the combination of PAHs that inhibit
CYP1 with PAHs that activate AhR might synergistically increase
toxicity (Staal et al., 2007; Timme-Laragy AR et al., 2007; Jayasundara
et al., 2015). Therefore, the increased toxicity observed here in re-
sponse to mixture exposure can be due to the interaction between AhR
activation and CYP inhibition. The importance of AhR activation was
further supported by the almost complete rescue of cardiovascular
toxicity in ZFE exposed to 6H-BPO, BaP or their mixture with the
protein expression of AhR knocked down by use of morpholinos. Si-
milarly, morpholino knockdown of AhR significantly rescued
Fig. 3. Relative gene expression of genes related with cardiovascular development and function (panels A – E; atp2a2, zerg, myh6, tbx5, and tnnt2) in ZFEs exposed to
oxy-PAHs alone (0.1–1.0 µM) or in combination with BaP (1 µM) between 24 and 96 hpf. Data are presented as means ± SE (n = 2–5). Analysis of statistical
differences between each exposure compared to the DMSO control was performed using one-way ANOVA (*P < 0.05, **P < 0.01, and ***P < 0.001). Student’s t-
test was used for statistical analysis to evaluate whether more or less than additive effects was observed in co-exposures compared to sum of single exposures
(XP < 0.05, XXP < 0.01, and XXXP < 0.001).
Fig. 4. Protein expression levels of Tbx5 and Zerg (A) in ZFEs exposed to oxy-PAHs alone (0.3 µM) or in combination with BaP (1 µM) between 24 and 96 hpf.
Densitometry analysis of normalized expression levels is shown in B. Actin was used as a loading control and DMSO was used as solvent control in all experiments.
Data are presented as means ± SE (n = 2–5) with *P < 0.05 as compared to control by one-way ANOVA.
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developmental toxicity in ZFE exposed to non-polar and polar fractions
of PAC contaminated soil extracts (Wincent et al., 2015a). Knockdown
of AhR also rescued developmental effects in ZFE caused by the oxy-
PAHs 1,9-benz-10-anthrone and benz[a]anthracene-7,12-dione
(Goodale et al., 2015). In addition, CYP1 expression is induced in ZFE
by larger oxy-PAHs, but not smaller PAHs such as 4H-CPO (Knecht
et al., 2013; Shankar et al., 2019). These data combined suggest that,
similar to PAHs, larger oxy-PAHs induce cardiotoxicity in an AhR-de-
pendent manner while smaller compounds do not. We could observe an
increase in the heart rate of ZFE injected with MO_AHR exposed to 6H-
BPO compared to the MO control. This could be due to AhR influence
on genes associated with cardiac function. However, more experiments
must be performed to study the mechanism behind this.
To further understand the mechanism of how oxy-PAHs and PAHs
might interact to cause cardiotoxicity, we studied expression of genes
and proteins involved in heart function (EC coupling), heart develop-
ment and structure. The results revealed a complex pattern of gene
expression changes. In general, the binary mixtures caused reduced
expression levels of atp2a2 and similar or increased expression levels of
zerg and tbx5, compared to single compounds. Principal component
analysis revealed that this expression pattern most strongly correlated
with effects on blood flow, pericardial edema and, formation of string
heart. Tbx5 plays an important role in heart development as well as a
role in cardiac conduction system function (Moskowitz IP et al., 2004)
and transcriptionally activates multiple cardiomyocyte lineage-asso-
ciated genes including atp2a2, myh6 and tnnt2. The gene atp2a2 is in-
volved in the regulation of heart contraction (Zhu et al., 2008), myh6 is
atrial-specific during the formation of the two chamber zebrafish heart
development (England and Loughna, 2013) and tnnt2 creates the tro-
ponin protein complex in cardiac muscle cells (Mikhailov and Torrado,
2016). The association between cardiovascular toxicity induced by
environmental pollutants and deregulation of these genes has been
studied previously. In mahi (Coryphaena hippurus) embryos exposed to
crude oil samples from the 2010 Deepwater Horizon disaster, mor-
phological and functional cardiotoxicities was associated with a general
down-regulation of cardiac-specific genes, including tbx5 and myh6
(Edmunds et al., 2015). In addition, an AHR2-dependent deregulation
of gene expression, including tnnt2, myh and atp2a1, was observed in
heart tissue from zebrafish embryos exposed to a mixture of BaP and
fluoranthene, and prior to onset of cardiac toxicity (Jayasundara et al.,
2015). It has furthermore been shown that activation of AhR signaling
by TCDD deregulates expression patterns of key cardiogenesis genes,
including tbx5, in the developing mouse heart, and that this is asso-
ciated with loss of cardiac function (Carreira et al., 2015). Similarly,
TCDD impaired the cardiac differentiation of human embryonic stems
cells via the AhR, which involved deregulated expression pattern of
Fig. 5. ZFEs injected with control morpholino (MO_ctr) (top row panels) or with AhR morpholino (MO_AhR) (bottom row panels) exposed to 6H-BPO alone (0.3 µM)
or in combination with BaP (1 µM) between 24 and 96 hpf. The heart is shown in green given by transgenic zebrafish [Tg (cmlc2:EGFP)]. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 2
Effects on cardiovascular related morphological and functional endpoints in cmlc2:GFP ZFEs at 96 hpf injected with MO_ctr or MO_AhR following exposure to 0.3 µM
6H-BPO alone or in combination with 1 µM BaP.
Pericardial edema (%) String heart (%) Heartbeat (BPM) Blood flow (%)
Cmlc2 embryos MO_ctr Control 0a 0 131 ± 4 3.2 ± 0.2
BaP 2.9 ± 1.8 0 121 ± 5 3.0 ± 0.2
6H-BPO 50 ± 10*** 27 ± 3.3*** 109 ± 4*** 2.2 ± 0.2*
6H-BPO + BaP 60 ± 5.8*** 43 ± 8.8**** 109 ± 5** 2.6 ± 0.4
Cmlc2 embryos MO_AhR Control 0 0 124 ± 3 3.1 ± 0.2
BaP 0 0 124 ± 5 3.7 ± 0.3
6H-BPO 0 0 140 ± 2*, ‡‡‡‡ 3.3 ± 0.2‡‡
6H-BPO + BaP 0 0 135 ± 5‡‡‡ 3.4 ± 0.3
a Results are presented as mean ± standard error, n = 3 – 10 replicates for morphological endpoints and n = 37 – 69 ZFEs for heartbeat and blood flow.
* P < 0.05.
*** P < 0.001.
**** P < 0.0001 as compared to control by Kruskal-Wallis (morphological endpoints) or one-way ANOVA (functional endpoints).
‡‡ P > 0.01.
‡‡‡ P < 0.001.
‡‡‡‡ P < 0.0001 as compared to MO_ctrl by Student’s t-test.
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tbx5 and tnnt2 among others (Fu et al., 2019). In contrast to our results,
upregulation of tbx5 and atpa2a2 was associated with an increased
heartbeat rate in zebrafish exposed to the flame retardant hex-
abromocyclododecane (Wu et al., 2013). Zerg protein levels were also
increased in embryos exposed to 6H-BPO, 4H-CPO and their mixtures.
Notably, cardiotoxicity was associated with reduced gene expression
levels of zerg (also known as kcnh2) in Atlantic haddock embryos ex-
posed to low levels of crude oil (Sorhus et al., 2016). The toxicity was
however found to be AhR-independent, which could explain this dif-
ference. Altogether, our results indicate complex mechanisms that seem
to differ between single oxy-PAHs but also among mixtures.
Activation of the AhR has been shown to induce expression of phase
I and phase II biotransformation enzymes, which are responsible for the
alteration of toxicokinetic processes of chemicals. To characterize tox-
icokinetic processes for single PAHs, internal concentrations over time
have been measured in rat (Viau et al., 1999), rainbow trout (Kennedy
and Law, 1990), Atlantic cod and haddock embryos (Sorensen et al.,
2017) and ZFE (Kuhnert et al., 2013). In accordance with the results
presented here, these studies demonstrated that the internal con-
centrations of PAHs, such as BaP, decrease over time and most likely
due to biotransformation as a result of AhR activation and CYP induc-
tion. In accordance to our results, Kuehnert et al showed that benz[a]
anthracene is biotransformed from 20 hpf old ZFEs (Kuhnert et al.,
2013). Wincent et al showed that CYP1 expression levels were induced
and enzyme activity enhanced by oxy-PAHs in vitro and in ZFE, which
indicated a potential capability of biotransformation of these com-
pounds in a comparable manner to PAHs (Wincent et al., 2015a,
Wincent et al., 2016). However, there is still limited data on the bio-
transformation rate of chemicals and identification of biotransforma-
tion products in ZFE. To the best of our knowledge, the time course of
internal concentrations of oxy-PAHs has not been reported previously.
In agreement with above discussions and implications for mixture
effects on biotransformation, the observed time profiles of the internal
concentrations for the mixture exposure differed from the single
Fig. 6. Time courses of concentrations for 6H-BPO and BaP alone or in combination in ZFE-free medium (A and B), in ZFE-medium (C and D) and in ZFE (E and F).
The concentration measurements of the binary mixture were only conducted until 96 hpf due to high lethality at 120 hpf. The lines represent simulated internal
concentrations using a one-compartment model. All values are stated as mean ± SE, n = 3–5. See also Table S2.
Fig. 7. Principal component analysis of data from ZFE exposed to the three oxy-PAHs, BaP and their mixtures. Panel A shows the individual factor map with four
clusters indicated by ellipses and B shows the variables factor map. EROD, MORT, PE, SH, YE, HB, BF and SB stands for EROD activity, mortality, pericardial edema,
string heart, yolk-sac edema, heartbeat rate, blood flow, and swim-bladder inflation, respectively. See also Table S3.
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exposures. In the mixture exposure, the internal concentration of 6H-
BPO significantly decreased over time which was in stark contrast to the
apparent accumulation that was observed when exposed as single
compound. In contrast, the internal concentration of BaP in the mixture
exposure was more stable compared to the single compound exposure
which showed a clear decrease over time. These results suggest that 6H-
BPO inhibits the metabolism of BaP and is further supported by the
observed potentiation of cyp1a gene expression which most likely was a
result of maintained levels of BaP that can continue to activate the AhR.
Together these data further strengthen that 6H-BPO act as a CYP1 in-
hibitor in ZFE. This observation also suggests that the rapid decrease of
6H-BPO when applied as a mixture was due to an increased bio-
transformation by other enzymes than CYPs. There is limited tran-
scriptomic data available on oxy-PAHs that could help to discern the
induction of possible alternative routes of metabolism. Available data in
ZFEs suggest that although certain responses such as redox homeostasis
are common, different oxy-PAHs give rise to different gene expression
profiles, and with no clear indication of what other types of bio-
transformation pathways are activated (Goodale et al., 2015; Geier
et al., 2018). A possible candidate could be the aldo-keto reductases
(AKRs). In mammalian models the AKR1C1 is inducible by planar
aromatics and can catalyze oxidation-reduction reactions of PAHs and
steroid hormones (Burczynski et al., 1999; Barski et al., 2008). This
family of enzymes is not well studied in zebrafish, and only the ex-
pression of AKR1A and AKR1B has been confirmed (NCBI Gene data-
base Accessed 2020-04-20b,a).
In conclusion, we show that similar to interactions between PAHs,
mixtures of PAHs and oxy-PAHs may cause increased developmental
and cardiovascular toxicity in ZFEs through an AhR-dependent me-
chanism. Our data adds further support to the importance of including
oxy-PAHs in risk assessment and monitoring of environmental pollution
(Clerge et al., 2019; Idowu et al., 2019). To increase the understanding
of the mechanism of action of different oxy-PAHs, and thus a better
basis for risk assessment, more data on transcriptomics are clearly
needed. In addition, qualitative and quantitative determination of
biotransformation products would further help to reveal the biochem-
ical mechanisms of cardiotoxicity as well as other adverse outcomes.
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